RT Journal Article
SR Electronic
T1 Pattern of variation in DNA methylation during pregnancy among mothers who delivered preterm in the GARBH-Ini cohort
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.02.21262698
DO 10.1101/2021.09.02.21262698
A1 Das, Jagyashila
A1 Bagchi, Indranil
A1 Ghosh, Shekhar
A1 Wadhwa, Nitya
A1 Nachu, Uma Chadramouli
A1 Thiruvengadam, Ramachandran
A1 Kshetrapal, Pallavi
A1 Bhatnagar, Shinjini
A1 Majumder, Partha P.
A1 Maitra, Arindam
A1 ,
YR 2021
UL http://medrxiv.org/content/early/2021/09/10/2021.09.02.21262698.abstract
AB Background DNA methylation (DNAm) may play an important role in birth outcomes.Material and Methods Genome wide DNAm was analysed in peripheral blood DNA of women at multiple time points during gestation. A novel empirical method was used to identify CpG sites with high temporal variance in methylation associating with preterm birth.Results High variability at 1296 CpG sites from the promoter regions of 1197 genes significantly associated with PTB. These genes belonged to pathways involved in signalling by platelet derived growth factor, platelet homeostasis, collagen degradation, extracellular matrix and circadian clock.Conclusions The findings provide novel information which might help in development of predictive biomarkers of preterm birth outcome.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the Department of Biotechnology, Ministry of Science and Technology, Govt. of India (BT/PR9983/MED/97/194/2013) and for some components of the biorepository by the Grand Challenges India-All Children Thriving Program (supported by the Programme Management Unit), Biotechnology Industry Research Assistance Council (BIRAC/GCI/0114/03/14-ACT). PPM acknowledges support of his J. C. Bose Fellowship. JD is supported by the Research Fellowship (NET) of the University Grants Commission (UGC), India.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approvals from Institutional Ethics Committees of Gurugram Civil Hospital, Translational Health Science and Technology Institute, National Institute of Biomedical Genomics and the collaborating hospitals were obtained.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe DNA methylation data of this study and the source codes are openly available in Gene Expression Omnibus at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE169338, under the study accession number GSE169338 and GitHub: https://github.com/Jagyashila/ptbmethylation respectively.